2-42656235-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001330442.2(MTA3):c.535G>A(p.Val179Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330442.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTA3 | NM_001330442.2 | c.535G>A | p.Val179Ile | missense_variant | 7/17 | ENST00000405094.2 | NP_001317371.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTA3 | ENST00000405094.2 | c.535G>A | p.Val179Ile | missense_variant | 7/17 | 5 | NM_001330442.2 | ENSP00000385823.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249182Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135186
GnomAD4 exome AF: 0.000215 AC: 314AN: 1461492Hom.: 0 Cov.: 30 AF XY: 0.000199 AC XY: 145AN XY: 727024
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.535G>A (p.V179I) alteration is located in exon 7 (coding exon 7) of the MTA3 gene. This alteration results from a G to A substitution at nucleotide position 535, causing the valine (V) at amino acid position 179 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at